Search

Billy Xiaoyi Pan, MD , has been named the 2017-2018 Richard J. Simmons and Ruthanne B. Simmons Glaucoma Fellow in the Harvard Department of Ophthalmology. This annual award was established in 2011 in recognition of two glaucoma physicians who were Harvard Ophthalmology graduates: the late Dr...

By Elizabeth Dougherty Sari Reisner, HMS assistant professor of pediatrics and an epidemiologist and researcher at Boston Children’s Hospital, is working to find ways to help school health professionals reduce the bullying of Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) students. Bryn...

Dr. Ahmad Sedaghat, of Massachusetts Eye and Ear/Harvard Medical School, has been named the recipient of the 2018 Eleanor and Miles Shore Fellowship Program Award for Scholars in Medicine. Launched in 1996, the Shore Fellowship Program is designed to help junior faculty at the instructor or...

NEW YORK — The Harvard Medical School has added to its LGBT-specific training over the last year with a new elective course devoted to gay health, more incorporation of LGBT issues in existing courses and a new LGBT scholarship NBC News reports. The elective course was unveiled in January, 2016 for...

In a new study, two professors are looking at bullying based on stigma -- where one is treated unfairly or unjustly due to one's race, sexual orientation, gender, or other characteristic -- and examining the methods used to prevent this type of bullying and address it when it happens. Read the story...

In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have been shown to be effective against Staphylococcus aureus and Enterococcus. The newly discovered...

Members of the LGBT community at HMS and HSDM came together—at a reception for the LGBT Advisory Committee and at National Coming Out Day —to celebrate past accomplishments and forge a new path for the future. Read the full story here.

Boston, Mass. — Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and...

New technology enables identification of biomarkers for a wide range of diseases. Read more here.

We are pleased to present our latest issue of Harvard Otolaryngology. Inside this issue: Mapping the Landscape of Head and Neck Cancer: Head and neck surgeons develop atlas that may help predict the likelihood of cancer spread Corneal Reinnervation: Surgeons develop new procedure to circumvent...